COST Action B22 on "Drug development for parasitic diseases"
2003-2007
Dissemination Plan
- E-mail network
- Network Links
- Meeting reports
- Notice of activities and events
- Scientific publications
Members of the MC are expected to take a pro-active role in the
dissemination of information about Action events and reports.
All members of the MC will
be linked by e-mail. It will be the responsibility of the MC
members for each country to maintain and update a list of key
laboratories/scientists in that country and ensure that the list
is available to other members of the MC. MC members will be
responsible for ensuring that those interested in the COST Action
are aware of activities and reports.
Mailing list: <costb22_at_icp.ucl.ac.be>
A WebSite will be established at the beginning of the COST Action on which all activities will be posted. Links will be established to other related Sites (e.g. to WHO/TDR, EC Programmes, other COST Actions).
A notice board will be provided for comments on activities, job adverts, techniques, and requests for materials.
Reports from all Meetings organised by the COST Action will be submitted to the Management Committee for approval and consideration of subsequent actions. It is anticipated that the Reports will take one of four forms:
a. An analytical review of the subject area (the previous COST B9 published reviews in peer reviewed international journals)
b. An overview of progress made in the area (a report on a COST B9 Congress was published in an international journal)
c. A report with Action points for Circulation to both the MC and a wider audience outside the COST Action
d. A report with Action points for Circulation to the MC and those who attended the Workshop when issues considered to be sensitive to drug development, for example patent issues, are discussed. The phrasing and legal standing of Confidentiality Agreements will be established through EC officials prior to these meetings.
The preparation of expert documents is considered to be an important component of the activity of the COST Action. The documents will provide up-to-date information and critical comments upon drug issues that may assist National and International Agencies in policy decisions and focus of future financial support from and the participation of the Pharmaceutical Industry.
Notice of Activities and Events
At the Annual Congress invited representatives from:
· WHO Tropical Diseases Research Programme (TDR), Geneva
· Medicines for Malaria Venture (MMV), Geneva
· International Organisation for Chemistry in Development (IOCD)
· Medicines sans Frontieres/Drugs for Neglected Diseases Group, Brussels
· IFPMA/EFPMA
· EC DG12
· Co-ordinators of projects under the EU's 5th and 6th Framework Programmes.
Will be briefed at a specific meeting held with the MC on proposed activities and events in the coming year to enable links and mutual priorities to be established. Copies of the Minutes from these briefing meetings will be sent to all those unable to attend.
Scientific Publications Resulting from the Action
A list of scientific publications and reviews will be maintained on the WebSite, with pdf where available. This will include both (a) publications of members of the COST Action and (b) publications derived from joint research projects that have developed from the COST Action and include authors from different EU laboratories.